Distolingual Infiltration Verses Conventional Nerve Block in Mandibular Third Molar Extraction

December 30, 2025 updated by: aimen zafar, Watim Medical & Dental College

Comparison of Efficacy of Distolingual Infiltration in Conjugation With Conventional Inferior Alveolar Nerve Block to Conventional Inferior Alveolar Nerve Block Alone for Extraction of Mandibular Third Molar

This randomized controlled trial will compare the effectiveness of adding distolingual infiltration to conventional inferior alveolar and buccal nerve blocks for mandibular third molar extraction. A total of 120 patients will be allocated into two groups. Pain during flap elevation and bone guttering will be assessed using the Visual Analogue Scale.

Study Overview

Detailed Description

Mandibular third molar extraction is a common oral and maxillofacial surgery procedure that requires profound local anesthesia. Despite conventional inferior alveolar, lingual and buccal nerve blocks, the distolingual gingiva may remain non-anesthetized due to accessory innervation via the mylohyoid and other nerves. Distolingual infiltration may improve anesthesia in this area.

This randomized controlled trial will enroll 120 patients requiring mandibular third molar extraction. Participants will be randomized into two groups: conventional inferior alveolar and buccal nerve block (Group A) and the same technique with additional distolingual infiltration (Group B). Pain during mucoperiosteal flap elevation and bone guttering will be recorded on a 0-10 Visual Analogue Scale. The primary objective is to determine whether distolingual infiltration improves pain control compared to the conventional technique.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Islamabad, Pakistan
        • Recruiting
        • Dr Aimen Zafar
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy individuals

    • Male and female
    • Age 18-45 years
    • Mandibular third molar impaction - all positions
    • Mandibular third molar impaction - all classes

Exclusion Criteria:

  • ASA status III and above

    • Patients requiring multiple extractions in the same appointment
    • Allergy to lignocaine
    • Patients in whom adrenaline is contraindicated
    • Medically compromised individuals e.g. poorly controlled diabetes, hypertension

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventional nerve block injection
Inferior alveolar and buccal nerve block using 2% lignocaine with adrenaline (1:80,000) without distolingual infiltration.
Standard inferior alveolar and long buccal nerve block for mandibular third molar extraction.
Experimental: conventional inferior alveolar with distolingual infilterate injection
Inferior alveolar supplemented with distolingual infiltration using 2% lignocaine with adrenaline (1:80,000).
Distolingual infiltration (0.2 ml) administered in addition to conventional inferior alveolar during mandibular third molar extraction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain during mucoperiosteal flap elevation
Time Frame: During mucoperiosteal flap elevation on the day of surgery

Pain intensity experienced during flap elevation will be assessed using the Visual Analogue Scale (VAS). This is a 0-10 point numerical scale where participants indicate the pain level experienced at the time of flap elevation.

Measurement Tool:

Visual Analogue Scale (VAS)

Scale:

  • Minimum score: 0 (no pain)
  • Maximum score: 10 (worst possible pain)
  • Directionality: Higher scores indicate worse pain
During mucoperiosteal flap elevation on the day of surgery
Pain During Bone Guttering
Time Frame: During bone guttering on the day of surgery.

Pain intensity during bone guttering will be recorded using the Visual Analogue Scale (VAS).

Measurement Tool:

Visual Analogue Scale (VAS)

Scale:

  • Minimum: 0 (no pain)
  • Maximum: 10 (worst pain)
  • Higher scores = worse pain
During bone guttering on the day of surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2024

Primary Completion (Estimated)

February 15, 2026

Study Completion (Estimated)

April 15, 2026

Study Registration Dates

First Submitted

November 26, 2025

First Submitted That Met QC Criteria

December 8, 2025

First Posted (Estimated)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

January 6, 2026

Last Update Submitted That Met QC Criteria

December 30, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • DSG-2023-335-4631-A

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain (Visceral, Somatic, or Neuropathic)

Clinical Trials on Conventional Inferior Alveolar and Buccal Nerve Block

Subscribe